© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
The vaccine from the University of Oxford and AstraZeneca uses a chimpanzee adenovirus vector.
These two integrase inhibitors are associated with high blood sugar and diabetes.
This may reflect loss of the weight-suppressing effect of the older version of the drug.
After years of taking daily oral cabotegravir and Edurant, people with suppressed HIV switched to long-acting injectable Cabenuva.
Black study participants switched from a regimen with two nucleoside/nucleotide reverse transcriptase inhibitors plus one other HIV drug.
Extended follow-up confirms that the long-acting monoclonal antibody works well for people with highly resistant HIV.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.